Anxiety and Depression

November 20, 2017

Natural product-derived therapy for anxiety and depression: Safranal, isolated from Saffron, Rooibos and among others, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 21/November/2017, 12.05 am

Natural product-derived therapy for anxiety and depression: Safranal, isolated from Saffron, Rooibos and among others, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 21/November/2017, 12.05 am https://genomediscovery.org/wp-content/uploads/2017/11/BTI-Figures-August-2017.pptx-removed-pictures.pptm-21.pptm-agents-that-inhibit-anxiety.depression.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/BTI-Figures-August-2017.pptx-removed-pictures.pptm-21.pptm-agents-that-inhibit-anxiety.depression.jpg2_.jpg November 20, 2017 November 20, 2017

Introduction: What they say: A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department of Stem Cell and…

November 17, 2017

Natural product-derived therapy for anxiety and depression: Valerian decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 17/November/2017, 7.50 am

Natural product-derived therapy for anxiety and depression: Valerian decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 17/November/2017, 7.50 am https://genomediscovery.org/wp-content/uploads/2017/11/Valerian-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-5-HTR2A-levels-attenuates-anxiety-and-depression2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/Valerian-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-5-HTR2A-levels-attenuates-anxiety-and-depression2.jpg November 17, 2017 November 17, 2017

November 16, 2017

Natural product-derived therapy for anxiety and depression: Sedanolide, isolated from Celery/Apium graveolens Var. dulce, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 16/November/2017, 11.47 am

Natural product-derived therapy for anxiety and depression: Sedanolide, isolated from Celery/Apium graveolens Var. dulce, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 16/November/2017, 11.47 am https://genomediscovery.org/wp-content/uploads/2017/11/Sedanolide-inhibits-PHF8JMJD1.2-expression-increases-Seratonin-receptors-5-HTR1AB-5-HTR2A-levels-attenuates-anxiety-and-depression.jpg2_.jpg3_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/Sedanolide-inhibits-PHF8JMJD1.2-expression-increases-Seratonin-receptors-5-HTR1AB-5-HTR2A-levels-attenuates-anxiety-and-depression.jpg2_.jpg3_.jpg November 16, 2017 November 16, 2017

November 12, 2017

Natural product-derived therapy for anxiety and depression: Cucurbitacin, isolated from Watermelon, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 13/November/2017, 12.17 am

Natural product-derived therapy for anxiety and depression: Cucurbitacin, isolated from Watermelon, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 13/November/2017, 12.17 am https://genomediscovery.org/wp-content/uploads/2017/11/Cucurbitacin-E-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5HTR1A.B-5HTR2A-levels-and-attenuates-anxiety-and-depression.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/Cucurbitacin-E-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5HTR1A.B-5HTR2A-levels-and-attenuates-anxiety-and-depression.jpg1_.jpg November 12, 2017 November 12, 2017

November 10, 2017

Molecular therapy for anxiety and depression: Rosiglitazone, an antidiapetic drug, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 11.49 pm

Molecular therapy for anxiety and depression: Rosiglitazone, an antidiapetic drug, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 11.49 pm https://genomediscovery.org/wp-content/uploads/2017/11/Rosiglitazone-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-5-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/Rosiglitazone-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-5-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg1_.jpg November 10, 2017 November 10, 2017

November 9, 2017

Molecular therapy for anxiety and depression: Agmatine decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 9.03 am

Molecular therapy for anxiety and depression: Agmatine decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 9.03 am https://genomediscovery.org/wp-content/uploads/2017/11/Agmatine-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5HTR1A.B-5HTR2A-levels-and-attenuates-anxiety-and-depression.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/11/Agmatine-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5HTR1A.B-5HTR2A-levels-and-attenuates-anxiety-and-depression.jpg1_.jpg November 9, 2017 November 10, 2017

Natural product-derived therapy for anxiety and depression: Valerian decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 17/November/2017, 7.50 am

Molecular therapy for anxiety and depression: Agmatine decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 9.03 am

Popular Post